Suma Gopinathan

All filings by Suma Gopinathan on record concern Lexicon Pharmaceuticals, Inc. Altogether 4 filings, all relating to 28 February 2026.

Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The latest filing, published on 3 March 2026, reports an option exercise in Lexicon Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.